1) 日本泌尿器科学会, 日本病理学会, 日本医学放射線学会, 他(編) : 精巣腫瘍取扱い規約 第4版. 金原出版, 東京, 2018
2) Kondo T, Hashimoto Y, Kobayashi H, et al : Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract : impact on patient survival. Int J Urol 17 : 848-854, 2010
3) Wells H, Hayes MC, O'Brien T, et al : Contemporary retroperitoneal lymph node dissection (RPLND) for testis cancer in the UK - a national study. BJU Int 119 : 91-99, 2017
4) Williams SB, McDermott DW, Winston D, et al : Morbidity of open retroperitoneal lymph node dissection for testicular cancer : contemporary perioperative data. BJU Int 105 : 918-921, 2010
5) Syan-Bhanvadia S, Bazargani ST, Clifford TG, et al : Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer : Minimizing Surgical Morbidity. Eur Urol 72 : 814-820, 2017
6) Inoue M, Nakatsuka S, Yashiro H, et al : Lymphatic Intervention for Various Types of Lymphorrhea. Access and Treatment Radiographics 36 : 2199-2211, 2016
7) 日本泌尿器科学会(編) : 精巣癌診療ガイドライン2015年版. 金原出版, 東京, 2015
8) Calaway AC, Foster RS, Adra N, et al : Risk of Bleomycin-Related Pulmonary Toxicities and Operative Morbidity After Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Good-Risk Germ Cell Tumors. J Clin Oncol 36 : 2950-2954, 2018